Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

@article{Lin2019FamilyAC,
  title={Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions},
  author={Pei-Jung Lin and Brittany D’Cruz and Ashley Ann Leech and Peter J Neumann and Myrlene Sanon Aigbogun and Dorothee Oberdhan and Tara A Lavelle},
  journal={PharmacoEconomics},
  year={2019},
  volume={37},
  pages={597-608}
}
Background and objectiveAlzheimer’s disease or dementia can impose a significant burden on family and other informal caregivers. This study investigated how the inclusion of family/informal caregiver spillover effects in a cost-utility analysis may influence the reported value of Alzheimer’s disease/dementia interventions.MethodsWe used PubMed to identify Alzheimer’s disease or dementia cost-utility analyses published from 1 January, 2000 to 31 March, 2018. We reviewed and abstracted… CONTINUE READING
BETA
4
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 97 REFERENCES

Patient Variability Seldom Assessed in Cost-effectiveness Studies.

  • Medical decision making : an international journal of the Society for Medical Decision Making
  • 2018
VIEW 1 EXCERPT